A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years

Scandinavian Journal of Urology and Nephrology

Volumn 37, Issue 3, 2003, Pages 195-201

  Larsson, Per ^a,b   Wijkström, Hans ^b   Thorstenson, Andreas ^b   Adolfsson, Jan ^b   Norming, Ulf ^c   Wiklund, Peter ^b   Onelöv, Erik ^a   Steineck, Gunnar ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

Bladder neoplasm; Grade; Prognosis; Progression; Recurrence; Stage; Survival; Transitional cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER IRRIGATION; BLADDER TUMOR; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; CYSTECTOMY; CYSTOSCOPY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; SWEDEN; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA, TRANSITIONAL CELL; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS; SWEDEN; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 0038049450     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365590310008037     Document Type: Article

References (15)

1. Heney NM. Natural history of superficial bladder cancer. Prognostic features and long-term disease course. Urol Clin North Am 1992; 3: 429-33.
2. Seddighzadeh M, Stenieck G, Jansson O, Larsson P, Wijkström H, Adolfsson J, et al. Low interleukin-1-alpha messenger RNA levels predict decreased overall survival time of patients with urinary bladder carcinoma. Br J Cancer 2001; 84: 329-34.
3. Bergren P, Steineck G, Adolfsson J, Hansson J, Jansson O, Larsson P, et al. P53 mutations in urinary bladder cancer. Br J Cancer 2001; 84: 1505-11.
4. Wijkström H, Steineck G. Bladder cancer, diagnosis, treatment and follow-up. Regional treatment programme. Stockholm: Oncology Centre, 1995 (in Swedish).
5. Bergkvist A, Ljungqvist A, Moberger G. Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand 1965; 130: 371-8.
6. Carbin BE, Ekman P, Gustafsson H, Christensen NJ, Sandstedt B, Silfversward C. Grading of human urothelial carcinoma based on nuclear atypia and mitotic frequency. J Urol 1991; 145: 968-71.
7. Mostofi FK, Davies CJ, Sesterhenn IA. Histological typing of urinary bladder tumours. International classification of tumours, No. 10, 2nd edn. Geneva, Switzerland: WHO, 1999.
8. International Union Against Cancer. TNM classification of malignant tumours, 3rd edn. Geneva, Switzerland: WHO, 1978.
9. Holmäng S, Hedelin H, Anderstrom C, Holmberg E, Busch C, Johansson SL. Recurrence and progression in low-grade papillary urothelial tumors. J Urol 1999; 162: 702-7.
10. Malmström PU, Busch C, Norlen BJ. Recurrence, progression and survival in bladder cancer. A retrospective study of 232 patients with >5 years follow-up. Scand J Urol Nephrol 1987; 21: 185-95.
11. Zieger K, Wolf H, Olsen PR, Hojgaard K. Long-term survival of patients with bladder tumours: the significance of risk factors. Br J Urol 1998; 82: 667-72.
12. Anderström C, Johansson S, Nilsson S. The significance of lamina propria invasion on the prognosis of patients with bladder tumours. J Urol 1980; 124: 23-6.
13. Parmar MK, Freedman LS, Hargreave TB, Tolley DA. Prognostic factors for recurrence and follow-up policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer. J Urol 1989; 142: 284-8.
14. Holmäng S, Hedelin H, Anderstrom C, Holmberg E, Johansson SL. Prospective registration of all patients in a geographical region with new diagnosed bladder carcinomas during a two-year period. Scand J Urol Nephrol 2000; 34: 95-101.
15. Holmäng S, Andius P, Hedelin H, Wester K, Busch C, Johansson SL. Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy. J Urol 2001; 165: 1124-8.